1. KDM4A Coactivates E2F1 to Regulate the PDK-Dependent Metabolic Switch between Mitochondrial Oxidation and Glycolysis
    Ling-Yu Wang et al, 2016, Cell Reports CrossRef
  2. Maternal expression of the histone demethylase Kdm4a is crucial for pre-implantation development
    Aditya Sankar et al, 2017, Development CrossRef
  3. Identification of novel JMJD2A inhibitor scaffold using shape and electrostatic similarity search combined with docking method and MM-GBSA approach
    Taotao Feng et al, 2015, RSC Adv. CrossRef
  4. KDM4C Activity Modulates Cell Proliferation and Chromosome Segregation in Triple-Negative Breast Cancer
    Jeison Garcia et al, 2016, Breast Cancer�(Auckl) CrossRef
  5. Small molecule KDM4s inhibitors as anti-cancer agents
    Hongzhi Lin et al, 2018, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
  6. null
    Chao Xu et al, 2015 CrossRef
  7. Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G(1)/S transition.
    Masaharu Kogure et al, 0 CrossRef
  8. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI
    Li-Liang Li et al, 2014, Breast Cancer Res CrossRef
  9. The role of the histone demethylase KDM4A in cancer
    Lissania Guerra-Calderas et al, 2015, Cancer Genetics CrossRef
  10. Novel 5-carboxy-8-HQ based histone demethylase JMJD2A inhibitors: Introduction of an additional carboxyl group at the C-2 position of quinoline
    Taotao Feng et al, 2015, European Journal of Medicinal Chemistry CrossRef
  11. null
    M.V. Botuyan et al, 2016 CrossRef
  12. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression
    Yi Su et al, 2017, BMC Cancer CrossRef
  13. Advances in histone demethylase KDM4 as cancer therapeutic targets
    Dong Hoon Lee et al, 2020, FASEB j. CrossRef
  14. The JmjN domain as a dimerization interface and a targeted inhibitor of KDM4 demethylase activity
    May Levin et al, 2018, Oncotarget CrossRef
  15. Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A
    Bing-Hao Wu et al, 2016, Oncotarget CrossRef
  16. Targeting USP1‐dependent KDM4A protein stability as a potential prostate cancer therapy
    Shu‐Zhong Cui et al, 2020, Cancer Sci CrossRef
  17. KDM4 Inhibition Targets Breast Cancer Stem–like Cells
    Eric Metzger et al, 2017, Cancer Res CrossRef
  18. KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer Cells
    William L. Berry et al, 2013, Cancer Res CrossRef
  19. The role of tumor suppressor short non-coding RNAs on breast cancer
    Shokooh Salimimoghadam et al, 2021, Critical Reviews in Oncology/Hematology CrossRef
  20. Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers
    Gaya Punnia-Moorthy et al, 2021, Front. Genet. CrossRef
  21. KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches
    Benluvankar Varghese et al, 2021, Front. Oncol. CrossRef